The cumulative risks for ovarian cancer by age 70 years were estimated to be 59% for BRCA1 carriers and 17% for BRCA2 carriers [103], and germline BRCA1 and BRCA2 mutations were exclusively associated with high-grade serous histology [104]. Here, BRCA2 is linked to ovarian cancer.